AzTrials
AzTrials

COPDNCT05061186

Resistive Expiratory Muscle Training in COPD Patients

A study testing Resistive Expiratory muscle Training Group and Conventional Breathing Exercise Group in people with COPD, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To determine effects of resistive expiratory muscle training on pulmonary functions in Chronic obstructive pulmonary disease (COPD) patients To determine effects of resistive expiratory muscle training on maximum expiratory pressure in COPD patients To determine effects of resistive expiratory muscle training on… Read more about this study

Who is it for?
Ages 40 to 70 years
Conditions the study is for
COPD
What is being tested?
Resistive Expiratory muscle Training Group and Conventional Breathing Exercise Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
1 sitePakistan
Study dates
10 Oct 2021to 15 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • COPD patients (GOLD criteria - moderate, moderately severe)
  • Borg scale < 4

Who cannot join

  • Patients with Orthopedic disease
  • Neurological disease,
  • Cognitive impairment (Mini-Mental State Examination < 22) ,
  • Heart diseases,
  • Pulmonary fibrosis
  • Obstructive sleep apnea syndrome.
  • Acute and chronic infections

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Holy Family Hospital

    Rawalpindi, Punjab Province, 44000

Other trials in Pakistan

About this study

Official title: Effects of Resistive Expiratory Muscle Training on Pulmonary Functions in Patients With COPD Patients

  • To determine effects of resistive expiratory muscle training on pulmonary functions in Chronic obstructive pulmonary disease (COPD) patients
  • To determine effects of resistive expiratory muscle training on maximum expiratory pressure in COPD patients
  • To determine effects of resistive expiratory muscle training on quality of life in COPD patients
Conditions
COPD
Being tested
Resistive Expiratory muscle Training Group, Conventional Breathing Exercise Group
Keywords
Resistive Expiratory Muscle training, Breathing Exercise, Pulmonary Function, Quality of Life
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistive Expiratory muscle Training GroupOther

    Mild Resistive Expiratory Technique [Expiratory Muscle Strength Training (EMST150)- six-week training protocol approximately 20 min per day] The EMST requires the participant to forcibly blow into the device for 5 seconds with sufficient pressure to open the one-way valve. Each "blow" is one repetition. The device will be set at a resistance of 30 cmH2O. Participants will be instructed to complete five sets of five repetitions (total of 25 times and approximately 20 minutes per day), any five days per week, for six weeks. Whole exercise will be done in sitting position. Rest between repetitions will be given according to comfort level of patient.

  • Conventional Breathing Exercise GroupOther

    Breathing Exercises: (approximately 20 minutes per day)

    ● Pursed lip breathing: (Sit with your back straight. Inhale through your nose for two seconds. Purse your lips like you're blowing on hot food and then breathe out slowly, taking twice as long to exhale as you took to breathe in. 4-5 times a day)

    ● Diaphragmatic breathing: (Lie on your back on a flat surface, knees bent and head supported. Use pillow under knees to support your legs. Breathe in slowly through your nose Tighten your stomach muscles, letting them fall inward as you exhale through pursed lips. Practice this exercise 5-10 minutes about 3-4 times per day).

    ● Incentive spirometer: (Hold in an upright position. Breathe in slowly and as deeply as possible. Hold your breath as long as possible (at least for 5 seconds). Then exhale slowly Rest for a few seconds and at least 10 times every hour)

Study groups in NCT05061186
Study groupRoleWhat they receive
Resistive Expiratory muscle Training GroupExperimentalMild Resistive Expiratory muscle Training Group
Receives: Other: Resistive Expiratory muscle Training Group
Conventional Breathing Exercise GroupActive comparatorBreathing Ex: Pursed lip Breathing, Diaphragmatic breathing ex, incentive spirometer
Receives: Other: Conventional Breathing Exercise Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum expiratory pressure

    Maximum expiratory pressure (MEP) measures the maximum positive pressure that can be generated from one expiratory effort starting from total lung capacity (TLC) . Changes will be assessed from the baseline and at the end of the intervention after 6 weeks

    Measured: 6 weeks

  2. St George's Respiratory Questionnaire

    This is a specific respiratory instrument developed for patients with COPD. Its validity, reproducibility and response to change over time have been demonstrated. It has three components: symptoms, activity and impact. The responses to the items can be aggregated into an overall score and three sub-scores for symptoms, activity and impact in the range 0-100%. Higher scores indicate a poorer quality of life).Changes will be assessed from the baseline and at the end of the intervention after 6 weeks

    Measured: 6 Week

  3. Forced Expiratory Volume in 1 second (FEV1)

    Changes from the Baseline, the digital spirometer is used in clinical setting to analyze Forced Expiratory Volume in 1 second FEV1 in Liters

    Measured: 6 Week

  4. Forced vital Capacity (FVC)

    Changes From the Baseline, the digital spirometer is used in clinical setting to analyze Forced vital Capacity in Liters.

    Measured: 6 week

  5. Peak Expiratory Flow (PEF)

    Changes from the Baseline, the digital spirometer is used in clinical setting to analyze peak expiratory flow PEF in Liter/second.

    Measured: 6 Week

  6. Volume of Lungs inflation

    The incentive spirometer is a device that encourages patients with visual and other positive feedback, to maximally inflate their lungs and sustain that inflation. It is a common mode of postoperative respiratory therapy and involves deep breathing facilitated by a simple mechanical device. Maximal volume of lung inflation is thought to open collapsed alveoli and thereby prevent and resolve atelectasis. When all three balls reached their column tops, it indicated that the subject was able to generate inspiratory airflow of 1200 ml/ml. When only two balls reached their column tops, it indicated that the subject generated 900 ml/min. When only one ball reached their column tops, it indicated that the subject could only generate 600 ml/min. Changes will be assessed from the baseline and at the end of the intervention after 6 weeks

    Measured: 6 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2021
  2. Study start10 Oct 2021
  3. Primary completion15 Jan 2022
  4. Study completion15 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05061186
Sponsor's protocol ID
REC/01082 Varda Farooq
Status last verified
Feb 2022
First submitted
18 Sep 2021
Last updated
2 Feb 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Resistive Expiratory muscle Training Group and Conventional Breathing Exercise Group in people with COPD, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum expiratory pressure (time frame: 6 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in